BioWorld Content on 'DILI'According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), drug-induced liver injury (DILI) is the leading cause of acute liver failure in the ...

The assay enables a broad range of longitudinal and endpoint testing for DILI-specific biomarkers from single- or repeat-dosing studies over a 14-day experimental window.

The global digital biomarkers market is set to witness a growth rate of 20% in the next 5 years. Rising prevalence of chronic diseases, growing adoption of wearables and smart devices, shift ...

Raúl J. Andrade教授：这是一个很有挑战性的问题。迄今为止，尚无明确的生物标志物能清晰地区分DIAIH和特发性或经典AIH。这两种疾病在临床表现、生化指标模式和组织学特征上往往存在显著重叠。

Biomarkers articles from across Nature Portfolio A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathological ...

Accessible through the Company’s CRS, the new offering harnesses the longstanding expertise of CN Bio’s scientific team to provide detailed data analysis, optimized outcomes, and data-driven ...

Explore how digital biomarkers are transforming clinical trials with real-time data, continuous monitoring and AI-driven patient insights.

The idea for The Dili Weekly as a weekly newspaper came about in 2007 after a discussion between two Timorese media professionals – Otelio Ote and Emanuel Braz. Read more ...

Down syndrome-related Alzheimer's disease is now considered a genetically determined form of Alzheimer's disease.1 The APP gene lies on chromosome 21; hence, people with Down syndrome overexpress APP.

Tumour biomarkers articles from across Nature Portfolio Tumour biomarkers is a term used to describe many different potential markers of cancer development and progression.

In the domain of histopathology analysis, existing representation learning methods for biomarkers prediction from whole slide images (WSIs) face challenges due to the complexity of tissue subtypes and ...